Sharon A. Baughman

Medicine · Health Sciences

8h-index3.0kcitations10works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(4), HER2/EGFR in Cancer Research(3), Platelet Disorders and Treatments(2), Estrogen and related hormone effects(2), Cancer Treatment and Pharmacology(2)

Publications10 total

Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys
Glycobiology·2007· 134 citedOpen Access
Pharmacokinetics and Pharmacodynamics of a Novel Depot Formulation of Abarelix, a Gonadotropin‐Releasing Hormone (GnRH) Antagonist, in Healthy Men Ages 50 to 75
The Journal of Clinical Pharmacology·2004· 18 cited
Tissue Disposition and Pharmacokinetics of Recombinant Human Nerve Growth Factor after Acute and Chronic Subcutaneous Administration in Monkeys
Drug Metabolism and Disposition·2000· 19 cited
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.
PubMed·1999· 300 cited
Genentech and Breast Cancer Advocacy
Breast Disease·1998· 3 cited
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.
Journal of Clinical Oncology·1998· 1.1k cited
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.
Journal of Clinical Oncology·1996· 1.4k cited
Pharmacokinetics and Pharmacodynamics of TP-9201, a gpIIbIIIa Antagonist, Administered in Combination with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin in Beagles
Journal of Cardiovascular Pharmacology·1996· 5 cited
Pharmacokinetics and Pharmacodynamics of TP-9201, a GPIIbIIIa Antagonist, in Rats and Dogs
Journal of Cardiovascular Pharmacology·1995· 16 cited
Percutaneous absorption of co-administered N-methyl-2-[14C]pyrrolidinone and 2-[14C]pyrrolidinone in the rat
Food and Chemical Toxicology·1992· 26 cited

Frequent Co-authors

José Baselga(3), Debu Tripathy(3), T. Twaddell(3), Christopher C. Benz(2), L Dantis(2), Nancy T. Sklarin(2), Andrew D. Seidman(2), J. Moore(2), Paul Peter Rosen(2), I. Craig Henderson(2), Larry Norton(2), Nishit B. Modi(2), Brian D. Paasch(2), John Mendelsohn(1), Clifford A. Hudis(1), Mark D. Pegram(1), A. Lipton(1), Daniel F. Hayes(1), Barbara Weber(1), D L Baly(1)